⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MGNX News
MacroGenics, Inc.
MacroGenics Reports First Quarter 2026 Financial Results and Highlights Business Transformation
globenewswire.com
MGNX
Form 8-K
sec.gov
MGNX
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
globenewswire.com
MGNX
PARP Inhibitors Clinical Trial Pipeline Accelerates as 25+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
AZN
MRK
JNJ
PFE
ABBV
GSK
ALLR
SNY
CURI
ORIC
EXEL
ABSI
LLY
TLX
FPH
BMY
SNX
XNCR
ZENA
ARVN
MGNX
DASH
VERU
GILD
EVGN
GEN
AMGN
MIR
RXRX
BG
MTX
BIO
Form 8-K
sec.gov
MGNX
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
globenewswire.com
MGNX
Margenza (MacroGenics) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
MGNX
Form 8-K
sec.gov
MGNX
FDA Removes Partial Clinical Hold on MacroGenics’ LINNET Study
globenewswire.com
MGNX
Neuroblastoma Market Analysis Report 2026-2030 | Rising Childhood Cancer Incidence Fuels Demand | Identify Lucrative Growth Segments for Investment Purposes
globenewswire.com
PFE
LLY
MGNX
LGND